Signal Detection Expertise Leverage MedAvante-ProPhase's two decades of experience in technology-enabled signal detection for CNS trials to position as a specialist partner for sponsors seeking robust, bias-reduced clinical outcomes and scalable rater training.

Independent Ratings Advantage Highlight the Independent Ratings model that reduces perception bias and safeguards against inconclusive results, offering a compelling value proposition for trials requiring high data integrity and regulatory confidence.

Global Reach Emphasize capabilities across the US, Germany, Russia, Japan and 40+ countries to attract multinational studies and trials with diverse site networks seeking centralized, standardized rating processes.

Tech-Enabled Platform Promote the Virgil Investigative Study Platform and clinician-designed, context-sensitive electronic rating forms as a differentiator for efficient data capture, remote monitoring, and consistent rater performance across sites.

Growth and Scale Target mid to large CNS trial sponsors by aligning with their expanding clinical programs and use cases for standardized ratings, independent validation, and scalable IT and operational support reflected in the company’s growth trajectory.